ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Estrella Immunopharma Inc

Estrella Immunopharma Inc (ESLA)

1,27
0,10
(8,55%)
Fermé 29 Décembre 10:00PM
1,28
0,01
(0,79%)
Après les heures de négociation: 1:59AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
1,27
Prix Achat
1,15
Prix Vente
1,35
Volume échangé
29 959
1,1698 Fourchette du Jour 1,31
0,63 Plage de 52 semaines 3,23
Cap du marché
Clôture Veille
1,17
Ouverture
1,17
Dernière Transaction
102
@
1.27
Dernière heure de transaction
Volume financier
US$ 37 308
VWAP
1,2453
Volume moyen (3 m)
39 101
Actions en circulation
36 179 147
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,33
Bénéfice par action (BPA)
-0,2
Chiffre d'affairess
-
Bénéfice net
-7,31M

À propos de Estrella Immunopharma Inc

TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Wilmington, Delaware, USA
Fondé
-
Estrella Immunopharma Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker ESLA. Le dernier cours de clôture d'Estrella Immunopharma était de US$1,17. Au cours de la dernière année, les actions de Estrella Immunopharma ont été négociées dans une fourchette de prix de US$ 0,63 à US$ 3,23.

Estrella Immunopharma compte actuellement 36 179 147 actions en circulation. La capitalisation boursière d'Estrella Immunopharma est de US$42,33 million. Estrella Immunopharma a un ratio cours/bénéfice (ratio PE) de -6.33.

ESLA Dernières nouvelles

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat...

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) ("Estrella", “Estrella Immunopharma”, or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.172715.73863118561.09731.291.02175931.15951145CS
40.1614.41441441441.111.4851.02583531.28300002CS
120.1715.45454545451.11.4850.63391011.07943565CS
260.330.92783505150.973.230.631167351.47878356CS
520.064.958677685951.213.230.63735811.40593331CS
156-3.94-75.62380038395.215.620.63768511.55951931CS
260-3.94-75.62380038395.215.620.63768511.55951931CS

ESLA - Frequently Asked Questions (FAQ)

What is the current Estrella Immunopharma share price?
The current share price of Estrella Immunopharma is US$ 1,27
How many Estrella Immunopharma shares are in issue?
Estrella Immunopharma has 36 179 147 shares in issue
What is the market cap of Estrella Immunopharma?
The market capitalisation of Estrella Immunopharma is USD 42,33M
What is the 1 year trading range for Estrella Immunopharma share price?
Estrella Immunopharma has traded in the range of US$ 0,63 to US$ 3,23 during the past year
What is the PE ratio of Estrella Immunopharma?
The price to earnings ratio of Estrella Immunopharma is -6,33
What is the reporting currency for Estrella Immunopharma?
Estrella Immunopharma reports financial results in USD
What is the latest annual profit for Estrella Immunopharma?
The latest annual profit of Estrella Immunopharma is USD -7,31M
What is the registered address of Estrella Immunopharma?
The registered address for Estrella Immunopharma is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
Which industry sector does Estrella Immunopharma operate in?
Estrella Immunopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
INTZIntrusion Inc
US$ 2,167
(381,56%)
187,57M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
557,72M
HUBCWHub Cyber Security Ltd
US$ 0,035
(250,00%)
2,65M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,75M
LITMSnow Lake Resources Ltd
US$ 1,61
(82,95%)
129,92M
NEUPNeuphoria Therapeutics Inc
US$ 4,11
(-92,30%)
940,73k
VIRXViracta Therapeutics Inc
US$ 0,16
(-32,49%)
9,47M
PRFXPainReform Ltd
US$ 3,48
(-28,98%)
949,52k
AIREreAlpha Tech Corporation
US$ 2,56
(-28,49%)
8,42M
AVGRAvinger Inc
US$ 0,9721
(-24,05%)
2,16M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
557,72M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,75M
RGTIRigetti Computing Inc
US$ 17,08
(10,62%)
298,47M
XTIAXTI Aerospace Inc
US$ 0,03935
(-1,63%)
263,01M
QSIQuantum Si Inc
US$ 3,585
(66,74%)
250,36M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock